METHYLDOPATE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Methyldopate Hydrochloride patents expire, and when can generic versions of Methyldopate Hydrochloride launch?
Methyldopate Hydrochloride is a drug marketed by Abraxis Pharm, Am Regent, Baxter Hlthcare, Hospira, Marsam Pharms Llc, Smith And Nephew, and Teva Parenteral. and is included in ten NDAs.
The generic ingredient in METHYLDOPATE HYDROCHLORIDE is methyldopate hydrochloride. There are three drug master file entries for this compound. Additional details are available on the methyldopate hydrochloride profile page.
Summary for METHYLDOPATE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 7 |
NDAs: | 10 |
Raw Ingredient (Bulk) Api Vendors: | 33 |
Patent Applications: | 173 |
Formulation / Manufacturing: | see details |
DailyMed Link: | METHYLDOPATE HYDROCHLORIDE at DailyMed |